Reference is made to the stock exchange notice issued on 7 January 2019 by Aqua Bio Technology ASA (the "Company) regarding, inter alia, results of the private placement described therein and in earlier stock exchange notices (the "Private Placement").

The following primary insiders have been allocated shares in the Private Placement:

The allocation in the Private Placement made by the Company's board of directors on 6 January 2019 imply that the following shareholders will surpass thresholds for mandatory notification of ownership:

Further, Chairman Edvard Cock has received proxies without voting instructions for a total number of 493,265 shares and votes, corresponding to 7.10% of the total outstanding shares and votes in the Company prior to the Private Placement.

This information is subject to the disclosure requirements pursuant to sections 4-2, 4-3 and 5-12 of the Norwegian Securities Trading Act.